Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer

BACKGROUND: Relatives of BRCA1 and BRCA2 mutation carriers have long been proposed by epidemiological studies to have an increased risk of developing prostate cancer. In the Ashkenazi Jewish (AJ) population, the existence of 3 frequent founder mutations, 185delAG and 5382insC in BRCA1 and 6174delT i...

Descrición completa

Detalles Bibliográficos

Publicado en:	BMC Med Genet
Principais autores:	Hamel, Nancy, Kotar, Kimberley, Foulkes, William D
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2003
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC194219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12911837/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2350-4-7
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!